Clinical trial
Haploidentical Stem Cell Transplantation for Patients With Hematologic…
NCT00186823 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00186823 |
|---|---|
| Title | Haploidentical Stem Cell Transplantation for Patients With Hematologic Malignancies |
| Official title | Haploidentical Stem Cell Transplantation Utilizing Purified CD34+ Hematopoietic Cells for Patients With Hematologic Malignancies |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia, Acute Lymphocytic (ALL), Myeloid, Acute(AML), Chronic(CML), Juvenile Myelomonocytic Leukemia(JMML), Hemoglobinuria, Paroxysmal Nocturnal (PNH), Lymphoma, Non-Hodgkin (NHL) and 1 more |
| Intervention type | Device, Drug, Procedure |
| Interventions | Miltenyi Biotec CliniMACS, Stem Cell Transplantation, TBI, systemic chemotherapy and antibodies as follows: |
| Enrollment | 57 |
| Start date | Mar 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | Jan 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 29, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: